OI was also used in peripheral blood mononuclear cells (PBMCs) isolated from patients with cryopyrin-associated periodic syndrome (CAPS), a class of diseases characterized by mutations in NLRP3 leading to spontaneous inflammasome activation (105). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.